| View |
|
DR-XY40922
|
Diclofenac Sodium
|
Defnac
|
25 mg/mL
|
Solution For Injection
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
The Searle Company Limited
|
Pakistan
|
Renewal
|
31 May 2024
|
15 June 2030
|
| View |
|
DR-XY40925
|
Ceftazidime
|
Argan
|
1 g
|
Powder For Injection (Im/Iv)
|
-
|
Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd.
|
China
|
-
|
10 November 2021
|
22 June 2025
|
| View |
|
DR-XY40929
|
Multivitamins + Minerals + Lysine + Taurine (see reverse for formulation)
|
Hi-Smart
|
(see reverse for formulation)
|
Syrup
|
Vitamins and Minerals
|
San Marino Laboratories Corp.
|
Philippines
|
Renewal
|
29 June 2024
|
02 August 2029
|
| View |
|
DR-XY40930
|
Felodipine
|
Ropine Er
|
5 mg
|
Extended Release Tablet
|
Calcium Channel Blocker
|
Myungmoon Pharm., Co., Ltd.
|
Korea
|
Renewal
|
20 June 2022
|
05 June 2027
|
| View |
|
DR-XY40931
|
Esomeprazole (As Magnesium Trihydrate)
|
Esofag
|
40 mg
|
Film Coated tablet
|
Proton Pump Inhibitor
|
Micro Laboratories Limited
|
India
|
Renewal
|
23 May 2022
|
22 June 2027
|
| View |
|
DR-XY40932
|
Co-Amoxiclav
|
Klavic
|
156.25mg/5mL
|
Powder For Oral Suspension
|
-
|
Swiss Parenterals Pvt. Ltd.
|
India
|
-
|
30 June 2020
|
31 May 2025
|
| View |
|
DR-XY40933
|
Latanoprost
|
Laprost
|
0.05 mg/mL
|
Opthalmic Solution
|
Anti-Glaucoma
|
Micro Labs Ltd.
|
India
|
Renewal
|
26 May 2022
|
01 June 2027
|
| View |
|
DR-XY40936
|
Iodixanol
|
Visipaque
|
550 mg/mL Solution for Injection (equivalent to 270
mg Iodine)
|
Solution for Injection
|
Contrast Medium (Iodinated X-ray Contrast Medium)
|
GE Healthcare Ireland Ltd.
|
Ireland
|
Initial (from Monitored Release Extension)
|
27 May 2022
|
04 June 2025
|
| View |
|
DR-XY40937
|
Iodixanol
|
Visipaque
|
652 mg/mL (equivalent to 320
mg Iodine)
|
Solution For Injection
|
Contrast Medium (Iodinated X-ray Contrast Medium)
|
GE Healthcare Ireland Ltd.
|
ireland
|
Initial (from Monitored Release Extension)
|
27 May 2022
|
04 June 2025
|
| View |
|
DR-XY40938
|
Exemestane
|
Emestane
|
25 mg
|
Film-Coated Tablet
|
Hormone Antagonist
|
Intas Pharmaceuticals Ltd.
|
India
|
Renewal
|
16 May 2022
|
22 June 2027
|
| View |
|
DR-XY40946
|
Potassium Chloride
|
None
|
150 mg/mL
|
Solution For Injection
|
Electrolyte or IV Additive Solutions
|
Amanta Healthcare Ltd.
|
India
|
Renewal
|
15 June 2022
|
25 June 2027
|
| View |
|
DR-XY40952
|
Docetaxel (As Trihydrate)
|
Taxotere
|
80 mg/4mL
|
Concentrate For Solution For IV Infusion
|
-
|
Sanofi-Aventis Deutscland GmbH
|
Germany
|
-
|
03 August 2020
|
17 September 2025
|
| View |
|
DR-XY40953
|
Docetaxel (As Trihydrate)
|
Taxotere
|
20 mg/mL
|
Concentrate For Solution For Iv Infusion
|
-
|
Sanofi-Aventis Deutscland GmbH
|
Germany
|
-
|
18 November 2020
|
17 September 2025
|
| View |
|
DR-XY40955
|
Cisatracurium (As Besilate)
|
Nimbex
|
2 mg/mL
|
Solution for Injection (IV)
|
-
|
GlaxoSmithKline Manufacturing S.P.A
|
Italy
|
-
|
17 March 2022
|
22 June 2025
|
| View |
|
DR-XY40959
|
Vancomycin (As Hydrochloride)
|
Imvaco
|
500 mg
|
Lyophilized Powder For Injection
|
Antibacterials (Glycopeptides)
|
Gufic Biosciences
|
India
|
Automatic Renewal
|
23 February 2022
|
19 June 2027
|
| View |
|
DR-XY40962
|
D-Alpha Tocopherol + Lecithin
|
Lecit-E 200
|
200 IU/ 500mg
|
Softgel Capsule
|
Vitamin
|
Shandong Yuwang Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
18 March 2022
|
20 June 2027
|
| View |
|
DR-XY40967
|
D-Alpha Tocopherol + Lecithin
|
Lecit-E 200
|
200 IU/500 mg
|
Softgel Capsule
|
-
|
Shandong Yuwang Pharmaceutical Co., Ltd.
|
|
-
|
11 May 2021
|
20 June 2025
|
| View |
|
DR-XY40971
|
Rosuvastatin (as Calcium)
|
Roswin
|
10 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Ajanta Pharma Ltd.
|
India
|
Automatic Renewal
|
07 June 2021
|
22 July 2026
|
| View |
|
DR-XY40975
|
Vancomycin (As Hydrochloride)
|
Imvaco
|
1 g
|
Lyophilized Powder For Injection (Iv Infusion)
|
ANTIBIOTICS (CEPHALOSPHORINS)
|
Gufic Biosciences Ltd.
|
India
|
Renewal
|
01 June 2022
|
21 June 2027
|
| View |
|
DR-XY40976
|
0.9% Sodium Chloride
|
None
|
0.90%
|
Solution For Irrigation
|
Parenteral Rehydration Solution (Electrolyte Solutions)
|
Shanxi Nuocheng Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
20 May 2022
|
21 June 2027
|